Please assess the completion status of the following clinical trial:

Trial Title: A Preliminary Study of 18F-AV-45 in Alzheimer's Disease and Healthy Elderly Volunteers

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: EARLY_PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria (AD group):~* Probable AD according to the National Institute of Neurological and Communication Disorders and Stroke-Alzheimer's Disease and Related Disorders Association (NINCDS-ADRDA) criteria~* Mild/moderate dementia as evidenced by a mini mental state exam (MMSE) score ranging from 10 to 24, boundaries included, at screening~* History of cognitive decline had been gradual in onset and progressive over a period of at least 6 months~Inclusion Criteria (healthy volunteer group):~* No evidence of significant cognitive impairment by history and psychometric testing~* MMSE of 29 or higher~Exclusion Criteria (both groups):~* Neurodegenerative disorders other than AD~* Cognitive impairment resulting from trauma, hypoxic damage, vitamin deficiency, brain infection, brain cancer, endocrine disease, or mental retardation~* Clinically significant infarct or possible multi-infarct dementia as defined by the NINCDS criteria~* Evidence on screening MRI or other biomarker that suggests alternate etiology for cognitive deficit (for healthy controls, evidence suggesting the presence of AD pathology)~* Clinically significant psychiatric disease~* History of epilepsy or convulsions~* Clinically significant hepatic, renal, pulmonary, metabolic, or endocrine disturbances~* Current clinically significant cardiovascular disease~* Received investigational medication within the last 30 days

- Gender: ALL
- Minimum Age: 50 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Subjects With AD (Type: EXPERIMENTAL): Probable AD, National Institute of Neurological and Communicative Disorders and Stroke-Alzheimer's Disease and Related Disorders Association (NINCDS-ADRDA) criteria, with mild/moderate dementia (Mini-Mental State Examination (MMSE) from 10 to 24)
- Healthy Elderly Subjects (Type: EXPERIMENTAL): Cognitively normal with MMSE of 29 or higher; age 50 years or older

Based on this trial design, predict the completion outcome and termination type (if applicable).